Related Experiment Video
Updated: Sep 10, 2026
Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Translation and validation of the IBD-disk for assessing disability in Spanish-speaking patients with inflammatory
Carlos González-Muñoza1, Antonio Giordano2, Cristina Gely2
1IBD Unit. Digestive Diseases , Hospital de la Santa Creu i Sant Pau, Spain.
Background And Aims:
Assessment of IBD patients based on patient reported outcome measures has an increasing interest worldwide for both clinical practice and biomedical research. One of the most common and easy-to-use tools is the IBD-Disk, which assesses the disability status of IBD patients. However, there is no validated version for Spanish-speaking patients. The aim of the study is to translate and validate a Spanish version of the IBD-Disk.
Methods:
The original English version of the IBD-Disk was translated, linguistically and culturally validated in a Spanish speaking cohort of IBD patients from Spain and Latin America and tested in comparison with the Spanish version of the IBD-disability index (IBD-DI) after 24 weeks of follow-up.
Results:
Globally, 102 patients were enrolled (52 Crohn's Disease and 50 ulcerative colitis). Internal consistency was 0.925 [95% CI: 0.902-0.945]. Intraclass correlation coefficient was 0.956 between baseline (T0) and week 1 (T1) [95% CI: 0.936-0.970] indicating satisfactory test-retest. Correlation with IBD-DI was 0.912 [95% CI: 0.872-0.940]. Activity indices were shown to be independent factors associated with IBD-Disk.
Conclusions:
The Spanish version of the IBD-Disk shows adequate internal consistency and test-retest, and convergent validity, thus confirming its utility in controlling global health status in IBD patients.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents